NCT06231979 is a Phase 4 clinical trial of Dexmedetomidine in Erector Spinae Block, sponsored by Assiut University.

Who is sponsoring NCT06231979?

NCT06231979 is sponsored by Assiut University.

What drugs are being tested in NCT06231979?

Interventions in NCT06231979: Dexmedetomidine, Bupivacain, Normal saline.

What condition does NCT06231979 study?

NCT06231979 studies Erector Spinae Block, Lumbar Fusion Surgeries, Dexmedetomidine.

Is NCT06231979 still recruiting?

NCT06231979 is currently status unknown. Last updated 30 January 2024.

Last reviewed 2024-01-30 · How we verify

NCT06231979

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Adding Dexmedetomidine to Bupivacaine for Bilateral Erector Spinae Block

Status unknown Phase 4 Last updated 30 January 2024

What this trial tests

Phase 4 trial testing Dexmedetomidine in Erector Spinae Block in 48 participants. Status unknown.

Timeline

25 February 2024

Primary endpoint
1 January 2025

1 October 2025

Quick facts

Lead sponsor	Assiut University
Phase	Phase 4
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	48
Start date	25 February 2024
Primary completion	1 January 2025
Estimated completion	1 October 2025

Drugs / interventions tested

Dexmedetomidine (dexmedetomidine) — full drug profile →
Bupivacain — full drug profile →
Normal saline

Conditions studied

Erector Spinae Block — all drugs for Erector Spinae Block →
Lumbar Fusion Surgeries — all drugs for Lumbar Fusion Surgeries →
Dexmedetomidine — all drugs for Dexmedetomidine →

Sponsor

Assiut University

Who can join

Adults 18 to 65, any sex, with Erector Spinae Block or Lumbar Fusion Surgeries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to compare the analgesic effect of bilateral US-guided ESPB using bupivacaine alone versus bupivacaine and DEX in lumbar fusion surgeries.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Dexmedetomidine

Trials testing the same drug.

NCT06824077 — Reducing Days DELirious With DEXmedetomidine as Part of an Intensive Care Unit Sleep Promotion Bundle · EARLY_PHASE1 · not yet recruiting
NCT07398066 — DEXmedetomidine for Postoperative Analgesia and Delirium Prevention After NEUROsurgery (DEX-NEURO Trial) · NA · not yet recruiting
NCT07377981 — An Exploratory Study of the Efficacy and Safety of Esketamine and Dexmedetomidine in Non-Intubated ICU Patients With Hyp · Phase 4 · not yet recruiting
NCT07306702 — Dexmedetomidine-Enhanced PCIA After Lobectomy in Nicotine-Dependent Patients · Phase 4 · withdrawn
NCT07482540 — Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery · NA · not yet recruiting

Other recruiting trials for Erector Spinae Block

Currently open trials in the same condition.

NCT07301528 — Comparison of ESP and QL Blocks for Postoperative Pain in Pediatric Appendectomy (ESP-QLB) · NA · recruiting
NCT07178262 — Erector Spinae Block in Reducing Peri-operative Opioid Consumption in Total Abdominal Hystrectomy · Phase 4 · recruiting
NCT07069101 — Continuous Erector Spinae Block Versus Continuous Edge of Laminar Block on The Quality of Analgesia and Diaphragmatic Ex · NA · recruiting
NCT06386770 — Systemic Versus Local Dexmedetomidine as An Adjuvant to Bupivacaine in Ultrasound Guided Erector Spinae Block · Phase 3 · recruiting

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06231979 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 30 January 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06231979.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing